Jian Liu

Jian Liu

Auto-generated profile, based on publicly available information

Jian Liu

Department of Neuroscience, California Pacific Medical Center Research Institute, San Francisco, CA 94107

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AGArie Gruzman
Arie Gruzman
WWWilliam L. Wood
William L. Wood
EAEvgenia Alpert
Evgenia Alpert
MPM. Dharma Prasad
M. Dharma Prasad
RMRobert G. Miller
Robert G. Miller
JLJian Liu
Jian Liu
Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron degenerative disease whose etiology and pathogenesis remain poorly understood. Most cases of ALS (≈90%) are sporadic (SALS), occurring in the absence of genetic associations. Approximately 20% of familial ALS (FALS) cases are due to known mutations in the copper, zinc superoxide dismutase (SOD1) gene. Molecular evidence for a common pathogenesis of SALS and FALS has remained elusive. Here we use covalent chemical modification to reveal an attribute of spinal cord SOD1 common to both SOD1-linked FALS and SALS, but not present in normal or disease-affected tissues from other neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases and spinal muscular atrophy, a non-ALS motor neuron disease. Biotinylation reveals a 32-kDa, covalently cross-linked SOD1-containing protein species produced not only in FALS caused by SOD1 mutation, but also in SALS. These studies use chemical modification as a novel tool for the detection of a disease-associated biomarker. Our results identify a shared molecular event involving a known target gene and suggest a common step in the pathogenesis between SALS and FALS.